awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q57903934-393B0086-F826-49B3-887E-635CFD9B0BD5
Q57903934-393B0086-F826-49B3-887E-635CFD9B0BD5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57903934-393B0086-F826-49B3-887E-635CFD9B0BD5
Ruxolitinib- but not fedratinib-induced extreme thrombocytosis: the combination therapy with hydroxyurea and ruxolitinib is effective in reducing platelet count and splenomegaly/constitutional symptoms
P2860
Q57903934-393B0086-F826-49B3-887E-635CFD9B0BD5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57903934-393B0086-F826-49B3-887E-635CFD9B0BD5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c6c264c28eaa4fa7faef733b30c53bd0d2178dce
P2860
Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation.